series-c-plus
Stage
2
Investors
About
T2 Biosystems is a medical diagnostics company that develops and commercializes instruments and molecular diagnostic panels, including the T2Dx instrument and T2Candida and T2Bacteria panels, to enable rapid detection of bloodstream infections and other pathogens. The company also maintains a pipeline of sepsis management products and panels for bacterial resistance and Lyme disease.
Explore T2 Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.